Biomerica's inFoods IBS shows 48.5% reduction in gastrointestinal pain, 49.8% in bloating.

Biomerica announces real-world data showing its inFoods IBS product delivered a 48.5% reduction in gastrointestinal pain and a 49.8% reduction in bloating over an 8-week period in over 360 patients. The company also launches a feedback platform to empower physicians to adjust patient treatment based on patient-reported outcomes. inFoods IBS identifies specific food triggers causing IBS symptoms, offering a personalized, non-drug solution.